Research and Clinical Trials

Title  
MK-1493A-024
Brief Description  
This trial is comparing the safety and efficacy of a new single tablet regimen (MK1439A) to current PI boosted regimen in HIV infected adults that are suppressed on their medications.
Who may be Eligible  
Adult patients with HIV who are currently taking Atazanavir, Kaletra or Darunavir for 6 months; Viral load is undetectable; Not be pregnant or planning to become pregnant or father a child during the study; Patient with acute hepatitis are excluded; Patients with chronic hepatitis are permitted as long as their therapy does not have activity against HIV; Must have stable maintenance labs (kidney, liver, hematology and cardiac function); No history of NNRTI use or virologic failure.
Specialty/Disorder  
HIV
Start Date  
07/15/2015
IRB Number  
CHS1-15-373
Principal Investigator  
Johnson, Marc
Contact Name  
Jessica

For More Information, Contact   Jessica  A.  Kearney-Bryan , BSN
Phone:  (704) 355-0244  Fax:  (704) 446-0000 
Email:  jessica.kearney-bryan@carolinashealthcare.org
Address:  1350 South Kings Drive, 3rd Floor
Myers Park Clinic
Charlotte, NC 28207
Close